Next-gen gene therapy vector for muscle diseases uses AI predictive methodology to improve efficacy and safety
Chief Executive Officer of Genethon. In neuromuscular diseases, the most widely used vector for transporting genetic material is the natural adeno-associated virus (AAV). However, a large ...
The Real Deal29d
COO Richard Lampen is retiring from Ellliman
Douglas Elliman’s chief operating officer Richard Lampen has retired ... He was previously an executive at Vector Group alongside Lorber until the firm sold to Japanese tobacco company ...